A comparative study of the anti-allergic effects of disodium baicalein 6-phosphate (BPS) and disodium cromoglycate (DSCG).
A comparative study was carried out on the effects of a soluble derivative of baicalein, disodium baicalein 6-phosphate (BPS) and disodium cromoglycate (DSCG) on the immediate type allergic reactions. BPS not only inhibited reaginic antibody-mediated reactions including antigen-induced mediator release from monkey lung, homologous PCA in rats, and reaginic antibody-mediated degranulation of mast cell, but also non-reaginic antibody-mediated reactions such as mediator release from guinea pig lung sensitized with ovalbumin and that from human lung caused by anti-IgE. The agent, however, did not affect the mediator release from lung of rats sensitized with dinitrophynylated ascaris extract plus Bordetella pertussis. On the other hand, DSCG showed characteristic properties as an inhibitor of reaginic antibody-mediated reaction. It is thus assumed that the functional site of reaginic antibody is well fixed with DSCG at a definite distance between the two-chromone-nuclei while that of IgG is readily fixed with the two molecules of baicalein or BPS.
D000818:Animals; D000937:Antigen-Antibody Reactions / Q000187:drug effects*; D004205:Cromolyn Sodium / Q000494:pharmacology*; D004305:Dose-Response Relationship, Drug; D005260:Female; D005419:Flavonoids / Q000494:pharmacology*; D006168:Guinea Pigs; D000882:Haplorhini; D006969:Hypersensitivity, Immediate / Q000276:immunology*; D007073:Immunoglobulin E; D008168:Lung / Q000276:immunology; D008297:Male; D008407:Mast Cells / Q000276:immunology; D008643:Mesentery / Q000166:cytology; D009943:Organophosphorus Compounds / Q000494:pharmacology; D010323:Passive Cutaneous Anaphylaxis / Q000187:drug effects; D051381:Rats; D011935:Reagins; D013329:Structure-Activity Relationship
D005419:Flavonoids; D009943:Organophosphorus Compounds; D011935:Reagins; D007073:Immunoglobulin E; D004205:Cromolyn Sodium